PP 86 Pharmacogenomic assays for CYP2D6*10 and CYP2D6*41 variants to predict response to tamoxifen
Channel: Sri Lanka Medical Association
Date: 26/07/2020

DESIGN AND IMPLEMENTATION OF NOVEL PHARMACOGENOMIC ASSAYS FOR CYP2D6*10 AND CYP2D6*41 VARIANTS TO PREDICT RESPONSE TO TAMOXIFEN THERAPY IN BREAST CANCER PATIENTS
Ranadeva NDK, Noordeen N, Wetthasinghe TK, Sirisena ND, Dissanayake VHW